drugset / Trial / NCT01258699

A Study Comparing the Pharmacokinetics of BK-C-0701 320mg, 480mg and Thiocacid HR Tab 600mg in Healthy Adult Male Subjects

NCT01258699

Phase 1 Completed 30 enrolled Bukwang Pharmaceutical
RandomizedParallel-groupOpen-labelTreatment

Summary

This study is Comparing the Pharmacokinetics of BK-C-0701 320mg, 480mg and Thiocacid HR Tab 600mg in Healthy Adult Male Subjects.

Timeline

Start
2009-08
Primary completion
Completion

Drugs

EvaluationDrugModalityDoseRoute
Subject BK-C-0701 Unknown 320 mg
Subject BK-C-0701 Unknown 480 mg
Comparator alpha-lipoic acid Small molecule 600 mg

Indications

No indication recorded.